Surgery for Recurrent Intrahepatic Cholangiocarcinoma

Surgery for Recurrent Intrahepatic Cholangiocarcinoma: a Promise or an Excess?

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04072250

Enrollment

216

Registered

2019-08-28

Start date

2017-06-01

Completion date

2018-10-30

Last updated

2019-09-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cholangiocarcinoma, Intrahepatic, Recurrence Cholangiocarcinoma, Re-hepatectomy

Keywords

Recurrent intrahepatic cholangiocarcinoma, Intrahepatic cholangiocarcinoma, Repeat hepatectomy, Metastasectomy

Brief summary

The investigators retrospectively reviewed the participants suffering from recurrent intrahepatic cholangiocarcinoma after curative resection and aimed to explore the predictive factors for recurrence and clarify the potential benefit of repeat hepatectomy or/with metastasectomy.

Interventions

PROCEDUREhepatectomy

Hepatectomy for patients with recurrent intrahepatic cholanigocarcinoma

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Inclusion criteria

* R0 resection for intrahepatic cholangiocarcinoma at initial diagnosis.

Exclusion criteria

* (1)Patient with R1 or R2 resection * (2)Distant metastasis noted when laparotomy * (3)Surgical mortality

Design outcomes

Primary

Measure	Time frame	Description
Survival	1977~2014	Including overall survival and disease free survival

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026